tiprankstipranks
Trending News
More News >
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market
Advertisement

Phathom Pharmaceuticals (PHAT) Revenue

Compare
525 Followers

Phathom Pharmaceuticals Revenue

Phathom Pharmaceuticals had a revenue of 39.50M in the quarter ending Jun 30, 2025, with 38.51%. This bring the company's revenue in the last twelve months to 114.04M, Decreased 39.31%. In the fiscal year ending Dec 31, 2024, Phathom Pharmaceuticals had annual revenue of 55.25M with 8001.47% growth.
Revenue (ttm)
114.04M
Revenue Growth
1049.81%
P/S Ratio
17.27
Revenue/Employee
$129,396
Employees
427
Market Cap
$954.19M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
55.25M54.57M+8,101.48%
Dec 31, 2023
682.00K-68,200,000.00%
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis